Chronic opioid use is associated with altered gut microbiota and predicts readmissions in patients with cirrhosis
Alimentary Pharmacology & Therapeutics2016Vol. 45(2), pp. 319–331
Citations Over TimeTop 10% of 2016 papers
Chathur Acharya, Naga S. Betrapally, Patrick M. Gillevet, Richard K. Sterling, Hamid I. Akbarali, Melanie B. White, Dinesh Ganapathy, Andrew Fagan, Masoumeh Sikaroodi, Jasmohan S. Bajaj
Abstract
Chronic opioid use in cirrhosis is associated with increased endotoxemia, dysbiosis and all-cause readmissions.
Related Papers
- → The Gut Microbiota and Liver Disease(2015)184 cited
- → Impacts of gut microbiota alteration on age-related chronic liver diseases(2023)29 cited
- Plasma gamma aminobutyric acid concentrations provide evidence of different mechanisms in the pathogenesis of hepatic encephalopathy in acute and chronic liver disease.(1989)
- Co-relation of high serum ammonia levels with severity of hepatic encephalopathy in chronic liver disease patients(2014)
- Zinc Level in Non-Cirrhotic Chronic Liver Disease and Cirrhosis: A Brief Report(2018)